Context: Emerging evidence has related the gut microbiome and circulating metabolites to human obesity. Gut microbiota is responsible for several metabolic functions, and altered plasma metabolome might reflect differences in the gut microbiome.
O besity has become a major global concern owing to its rapid increase in prevalence and the vast economic burden. Parallel with this development, a rapid increase in the prevalence of type 2 diabetes and cardiovascular disease, collectively referred to as cardiometabolic diseases (CMDs), has been recorded worldwide.
Using metabolomics, numerous studies have reported alterations in circulating metabolite levels in individuals with obesity and CMDs (1) (2) (3) . In particular, branchedchain and aromatic amino acids (BCAAs) have been suggested to be of etiological importance, with prospective studies showing them to predict for both future diabetes (4, 5) and cardiovascular disease (6) (7) (8) in several cohorts.
Several underlying mechanisms for elevated levels of BCAAs and other metabolites have been proposed, including dietary intake, genetic factors, and gut (fecal) microbiome (5, 9, 10) . In recent years, the role of gut microbiota in influencing circulating levels of metabolites have gained increasing attention, fortified by reports that such metabolites could be mediators in the connection between gut microbiota and CMDs (11) (12) (13) .
Evidence suggests a connection between the gut microbiome and CMDs and several of the CMD risk factors, including obesity (14, 15) , insulin resistance (16) , and atherosclerosis (17) . However, the reported relationship between obesity and gut microbiota has differed among studies, mostly depending on the study design. Studies of germ-free mice have suggested a causal role of the gut microbiota in the development of obesity. However, recent, large population-based studies and meta-analyses of smaller human studies have only shown very small, although statistically significant, associations between gut microbiota composition and obesity (18) (19) (20) . Although a link between the gut microbiota and CMDs has been established, the mechanisms of bacterial actions on the host have been insufficiently detailed. In terms of the intersection between gut microbiota and plasma metabolites, the best studied are probably the effects on bacterially produced short-chain fatty acids and secondary bile acids (21) . However, most of these studies were performed in case-control settings or represent animal or cell studies and might, therefore, not resemble the situation in the general population. A recent study showed a lower abundance of the glutamatefermenting gut bacteria Bacteroides thetaiotaomicron in obese individuals compared with lean controls, which was mirrored by elevated circulating levels of glutamate (22) . Weight loss intervention by sleeve gastrectomy in obese individuals and gavage of B. thetaiotaomicron in mice increased the abundance of B. thetaiotaomicron and decreased the levels of glutamate (22) .
The cited studies have indicated the importance of the intersection of gut microbiota and plasma metabolites in CMD and thus stress the need for more detailed investigations of the involvement of gut microbiota in modulating the levels of plasma metabolites in a general population. Because obesity is a strong risk factor for CMDs, we aimed to find a metabolite profile associated with body mass index (BMI) and to test whether such a profile is connected to a distinct composition of the gut microbiota in a large, predominantly healthy population. Given previous data, we focused on a panel of 48 metabolites, including amino acids, acylcarnitines, bile acids, and tricarboxylic acid cycle intermediates.
Materials and Methods
The Malmö Offspring Study is a population-based cohort study in which adult (age .18 years) children and grandchildren of participants in the Malmö Diet and Cancer-Cardiovascular Cohort (23) were recruited. Participants were invited by letter and visited the research clinic on two occasions. At the first visit, venous blood was drawn after an overnight fast, the anthropometrics were measured, and the study participants were instructed on how to collect the fecal samples at home. The inclusion criterion for the Malmö Offspring Study was a parent or grandparent in the Malmö Diet and Cancer-Cardiovascular Cohort; no exclusion criteria were used. The ethics committee of Lund University approved the study protocols for reexamination (protocol number, DNR 2012/594), and all participants provided written informed consent.
Anthropometric measurements
The participants' height (m) was measured to the nearest centimeter directly under the meter with the participant looking straight ahead, the legs together, and wearing indoor clothing without shoes or hats. Weight (kg) was measured using a calibrated balance beam or digital scale. 
Diet and physical activity
The participants were asked to complete a 4-day food record using the Riksmaten 2010, developed by the Swedish National Food Institute. From these data, macronutrient and fiber intake were calculated, and energy was adjusted by dividing the intake with the nonalcohol energy intake (24) .
Physical activity was assessed by a question regarding leisure time physical activity. The participants were considered to be physically active if conducting moderate physical activities at least one time weekly.
Gut microbiota sequencing
Fecal samples were collected in plastic tubes at home and stored in the home freezer until they were brought to the clinic, where they were stored at 280°C. The microbial DNA was extracted using the QIAamp column stool kit (base pairs; Qiagen, Hilden, Germany), and the V1-V3 region of the 16S ribosomal RNA gene was amplified and sequenced using a HiSeq sequencing system (Illumina, San Diego, CA) at GATC Biotech (Constance, Germany). The fastq files were then aligned by FLASH (fast length adjustment of short reads) and binned together to operational taxonomical units using QIIME (quantitative insight into microbial ecology) (25, 26) . The sequences were matched with the reference database Greengenes, version 13.8 (Second Genome Inc, San Francisco, CA). Microbes that only occurred once or twice in the data set and low-abundant bacteria (,0.01%) were removed, leaving 62 bacteria characterized at the genus level and belonging to eight microbial phyla for further analysis.
Liquid chromatography-mass spectrometry analysis
Metabolite profiling was performed in EDTA plasma using targeted liquid chromatography-mass spectrometry (LC-MS) with an ultra-high performance LC-quadrupole time-of-flight MS system (Agilent Technologies, Santa Clara, CA). Plasma samples were removed from storage at 280°C and thawed on ice. The extraction of metabolites was performed by adding 120 mL of extraction solution (methanol/water, 80:20, containing internal standards labeled with stable isotopes) to 20 mL of plasma, with subsequent mixing at 1250 rpm for 1 hour. A detailed description of the internal standards is listed in Supplemental Table 1 . After incubation, the samples were centrifuged for 20 minutes at 14,000g and the supernatants transferred to glass vials for LC-MS analysis. The samples were analyzed in both positive and negative ion modes to measure 48 metabolites. Analyses using positive polarity LC-MS were performed as previously described (27) . For negative ion polarity LC-MS, the samples were separated on an ACE C18 column (1.7 mm; 2.1 3 100 mm; Advanced Chromatography Technologies Ltd., Aberdeen, UK) using gradient elution (mobile phase A, water with 0.1% formic acid; mobile phase B, acetonitrile with 0.1% formic acid) with a flow rate of 0.3 mL/min. The gradient was as follows: 0 to 5 minutes, 0% to 15% B; 5 to 13 minutes, 15% to 95% B; 13 to 15 minutes, 95% B; 15 to 16 minutes, 95% to 0% B; 16 to 18 minutes, 0% B. Subsequent MS analysis was performed with settings similar to those for positive ion polarity LC-MS analysis. The metabolites were quantified by calculating the area ratio to each metabolite's isotope-labeled internal standard, followed by multiplying by the known concentration of the internal standard.
Statistical analysis
Orthogonal partial least squares regression (OPLS) was performed to simultaneously analyze correlations between the 48 measured metabolites and the BMI (28). The systematic variation in the metabolite levels was defined as the variation that correlated with the BMI (predictive) and the variation that did not correlate with the BMI (orthogonal). The metabolite data were mean-centered and unit variance-scaled before analysis, and the model performance was validated using sevenfold cross-validation. Analysis using OPLS was performed in SIMCA, version 14.1 (Sartorius Stedim Biotech, Göttingen, Germany).
Linear regression models, adjusted for age and sex, were used to analyze the relation between the circulating metabolite levels and BMI. Spearman correlations were applied to investigate the relationship between the OPLS component and the bacteria at the phylum and genus levels. Owing to the skewed distribution of the bacteria at the genus level and because the conditional distribution of most bacteria at the genus level is overdispersed, negative binomial regressions adjusted for age and sex were used for further analysis. The Shannon diversity index (a-diversity) and Bray-Curtis distance metrics (b-diversity) were calculated using QIIME. Linear regression and Spearman correlation analysis was performed in R, version 3.3.0 (R Foundation, Vienna, Austria), and negative binomial regression was performed in STATA, version 15 (StataCorp LP, College Station, TX). Statistical significance was defined using Bonferroni-adjusted P value threshold to adjust for multiple testing. Associations between plasma metabolites and BMI were statistically significant at P , 0.001, and correlations between gut microbiota genera and principal component predictive of BMI (PC BMI ) were statistically significant at P , 0.0008.
Results
The participants in the present study consisted of 920 individuals with a mean age of 39 years; 53% were women. Gut microbiota sequencing was performed for the 674 individuals who provided stool samples ( Table 1 ).
The individuals without stool samples did not differ from the whole cohort in terms of traditional cardiometabolic risk factors.
Association between plasma metabolites and BMI
Using OPLS, the correlations between the 48 measured plasma metabolites and BMI were analyzed in 920 individuals, resulting in one PC BMI and two BMI-unrelated orthogonal principal components. The model parameters (R2Y = 0.365 and Q2Y = 0.313) indicate that the model explains 36.5% of the total variation in BMI and predicts 31.3% after a sevenfold cross-validation. PC BMI separated lean, overweight, and obese study participants, as indicated by the OPLS score plot (Fig. 1) . Of the 48 measured metabolites, 25 had statistically significant loadings (P , 0.05) and contributed to the BMI predictive model (Fig. 2) . Glutamate, BCAAs, and BCAA-related metabolites dominated the positive contributions to the model. Serine, asparagine, threonine, and citric acid had substantial negative contributions.
The association between the individual metabolite levels and BMI was evaluated using linear regression models. In total, 19 metabolites were associated with BMI using a Bonferroni-adjusted P value cutoff of 0.001 (Fig. 3) . The results from the linear regression analyses were highly concordant with the multivariate analysis, with all 19 significant metabolites also contributing to the OPLS model. However, six metabolites contributed to PC BMI despite the lack of an association between their individual circulating levels and BMI. Glutamate displayed by far the strongest positive association with BMI (P = 5.2e-53), followed by eight metabolites related to BCAA metabolism (P , 0.001 for all). The individual metabolites with statistically significant inverse relations with BMI included serine (P = 2.7e-6), citrate (P = 9.1e-5), and asparagine (P = 2.0e-6), concordant with their contribution with negative loadings in the OPLS model.
PC BMI was also associated positively with several traditional CMD-associated traits, including waist circumference, fasting glucose, low-density lipoprotein cholesterol, triglycerides, and systolic blood pressure and negatively with high-density lipoprotein cholesterol. Furthermore, PC BMI was associated negatively with dietary fiber intake, and participants with a higher PC BMI were more often smokers and had greater odds of being physically inactive and having a family history of diabetes (Supplemental Table 2 ). 
Association between BMI-associated metabolites and gut microbiota composition
The connection between BMI-associated metabolites and gut microbiota was investigated by assessing the associations between the eight gut microbial phyla and the PC BMI . Proteobateria (P , 0.001), Actinobacteria (P = 0.013), and Spirochaetes (P = 0.002) were associated positively with the PC BMI . Additionally, we observed a negative association between the Shannon diversity index and the PC BMI (P = 0.016) and a positive association between the Bray-Curtis dissimilarity and the PC BMI (P = 0.03). All data are presented in Supplemental Table 3 .
Next, the 62 microbiota genera were analyzed for their correlation with the PC BMI using Spearman correlation. The PC BMI correlated positively and significantly with three genera in the Lachnospiraceae family (Blautia, Dorea, and Ruminococcus). Statistically significant negative correlations were found with SHA-98 and unidentified genera in the Clostridiaceaeo and Rikenellaceae families (Fig. 4) .
We next used negative binomial regression to investigate whether the relationships between the PC BMI and the bacterial genera were independent of age and sex. A strong positive association was found between PC BMI and genera in the Lachnospiraceae family, after adjusting for age and sex. SHA-98 showed a substantial negative association with the PC BMI ( Table 2 ). The three Lachnospiraceae genera were also associated positively with the BMI, and SHA-98 was associated negatively with the BMI. The genera in the Clostridiaceae and Rikenellaceae families were associated with neither the PC BMI nor the BMI after adjustment for age and sex. The recent use of antibiotics or the presence of diabetes did not significantly influence the results, as evident from sensitivity analyses in which individuals reporting antibiotic use within the past 6 months (15.7%) and patients with diabetes (3.1%) were removed (Supplemental Table 4 ).
Association between gut bacteria and BMI is dependent on plasma metabolites Because we found that both certain plasma metabolites and gut bacteria are associated with BMI, we investigated whether these associations are independent signals or whether the covariation between metabolites and gut bacteria might represent shared pathways in relation to obesity. To address this, the PC BMI was used as a covariate, together with each of the gut bacteria significantly associated with the PC BMI in a linear regression of BMI. Among the four bacteria associating with BMI, none remained associated with BMI after adjusting for age, sex, and metabolite PC BMI . Adding all four bacteria in addition to PC BMI , age, and sex in a linear regression model on BMI did not improve the model compared with the model without the inclusion of any gut bacteria (r 2 = 0.37), suggesting that most of the contribution of gut bacteria to the BMI is contained within the information from the PC BMI .
Discussion
The key findings of our population-based study were that plasma glutamate and BCAA-related metabolites are strongly associated with obesity and that gut bacteria, in particular, the Blautia, Dorea, and Ruminococcus genera in the Lachnospiraceae family and SHA-98, were related to both the BMI-related metabolites and BMI. Most of the contribution of gut bacteria to the variation in BMI was contained within the variation of glutamate and BCAA-related metabolites, indicating that the bacteria and plasma metabolites are in the same chain of events in relation to obesity, rather than being independent factors. Using OPLS, we constructed a metabolite PC (PC BMI ) that strongly predicted for BMI in our population of generally healthy individuals. The metabolite PC BMI was also associated with all the other measured CMD-associated Negative binomial regressions were performed on gut microbiota genera, with all analyses adjusted for age and sex.
doi: 10.1210/jc.2017-02114 https://academic.oup.com/jcemtraits and with known environmental risk factors for CMD such as physical inactivity, smoking, and low dietary fiber intake. Concerning the gut microbiota, the PC BMI was associated with a lower a-diversity and higher b-diversity, in line with previous findings (i.e., obese individuals have been observed to have less diverse, yet potentially more heterogeneous, microbiota) (18, 22) . We did not observe any associations between either the PC BMI or the BMI with the relative abundance of Bacteroidetes or Firmicutes, nor their ratio, which pre. viously have been observed to associate with the BMI in some studies (20) . However, other recent populationbased studies also did not observe these associations (18, 29, 30) . Four different gut bacteria on the genus level, three of which belong to the Lachnospiraceaeo family, were associated with both BMI and PC BMI . Comparing the predictive ability of linear regression models on BMI, using either the PC BMI or the four gut bacteria as predictors, we found that the model with PC BMI explained more of the BMI variability. When adding the four genera, in addition to the PC BMI , the predictive ability of the model remained similar, and none of the microbial genera was associated with BMI after adjusting for age, sex, and the PC BMI . Thus, although the total variation of BMI-related metabolites is controlled by many factors other than gut bacteria, such as genetic factors and the external induction of enzymes, our results indicate a shared etiology for gut microbes and the BMI-predictive metabolites. To investigate the mechanisms behind such shared associations was not within the scope of the present study but could be either a direct result of altered bacterial metabolism of the BMI-predictive metabolites or reflect secondary effects mediated by gut microbial metabolism.
The by far strongest predictor of BMI in our study, glutamate, has previously been associated with BMI in a few cohorts (3, 22, 31) , and others have failed to show any such relationship (32) . A recent study by Liu et al. (22) reported a markedly decreased abundance of B. thetaiotaomicron, a glutamate-fermenting commensal, in the gut microbiota of obese individuals. Furthermore, the abundancy of B. thetaiotaomicron correlated inversely with the serum glutamate concentration and with the increased abundance of several bacterial species containing genes involved in glutamate synthesis. Consistent with our results, Dorea longicatena expression correlated with obesity and increased levels of glutamate. Furthermore, the study showed that gavage of B. thetaiotaomicron in mice consuming a high-fat diet protected against increased adiposity and weight gain. In humans, sleeve gastrectomy was shown to increase the abundance of B. thetaiotaomicron and decrease the circulating levels of glutamate (22) . These observations suggest that targeting the gut microbiota could be a future weight loss intervention and that the effects from such an intervention could be mediated partly through plasma metabolites such as glutamate.
We identified strong cross-sectional associations between BMI and 19 different metabolites, of which the 8 strongest predictors were BCAAs or related metabolites. We thus validated the importance of BCAA metabolism in obesity by showing that increased levels of all BCAAs (valine, leucine, and isoleucine) and downstream BCAA metabolites, such as branched-chain keto acids (3-methyl-2-oxovalerate, a-ketoisovalerate, and a-ketoisocaproate) and short-chain acylcarnitines (propionylcarnitine and isovalerylcarnitine), are associated with a greater BMI. Furthermore, glutamate and alanine are byproducts of the aminotransferase action when BCAAs are forming branched-chain keto acids in the first step of BCAA catabolism. Also, multivariate analysis of the connection between metabolites and BMI in our study displayed a strong involvement of the BCAA axis in predicting the BMI, which was indicated by all BCAAs and related metabolites contributing significantly to the model and that the five greatest positive contributions were related to BCAAs. Several earlier studies have found BCAAs associated with obesity (1, 3, 30, 31) and other risk factors for CMDs (3, 33) and to predict the future onset of type 2 diabetes (4, 34) and cardiovascular disease (6, 8) . We showed that the BMIpredictive metabolite component, dominated by glutamate, BCAAs, and related metabolites, was associated with four distinct microbiota genera. Three of the genera, Blautia, Dorea, and Ruminococcus, which were associated positively with the metabolite component, are all members of the Lachnospiraceae family, one of the most abundant families of gut microbes. Consistent with our results, in a recent study of 531 Finnish men, Blautia was associated with a greater BMI and increased levels of circulating BCAAs and alanine (35) . To the best of our knowledge, L. dorea and L. ruminococcus have not been previously found to be connected to the plasma BCAA levels; however, they have been found to be associated with the metabolic syndrome and weight gain (18, 36) . We also found associations between two bacteria, SHA-98 and a genus in the Rikenellaceae family, and lower levels of the PC BMI . These genera were also associated with a lower BMI, in line with a recent study that reported Rikenellaceae and SHA-98 to be connected with a healthier metabolic state (36) . However, in our study, we found that the associations between Rikenellaceae and BMI and BMI-related metabolites, were not substantial after adjusting for age and sex. Circulating BCAA levels have recently been suggested to be affected by several different gut bacterial species. A Danish study of insulin-resistant individuals reported that plasma BCAA levels correlated with the bacterial species Prevotella copri and Bacteroides vulgatus. Moreover, gavage of P. copri into healthy mice increased their circulating BCAAs and caused insulin resistance. That study also concluded that the abundance of gut microbial species encoding genes for BCAA biosynthesis correlated with increased insulin resistance, and the opposite relationship was seen for bacterial species encoding genes involved in the uptake of BCAAs (11). Liu et al. (22) found that the genes involved in BCAA degradation were depleted in obese individuals and that circulating BCAAs, similar to glutamate, correlated with a lower abundance of Bacteroides species. This suggests that the gut microbiota could affect the circulating BCAA levels by controlling BCAA abundance in the gut. This notion has been supported by previous findings of a greater cecal abundance of BCAAs in obese mice compared with that in lean control mice (37) . We have fortified the connection between BCAAs and gut microbiota by identifying associations with four gut microbiota genera, three of which, to the best of our knowledge, are novel findings.
The present study had several strengths and limitations. We could not prove causality owing to the crosssectional study design. Also, 16S sequencing did not allow us to study the bacteria at the species level. Furthermore, the nature of our targeted metabolomics approach allowed for precise metabolite measurements but was limited to predefined target metabolites. However, our study included a large number of healthy participants with a wide age span, enabling us to investigate the question of interest in a normal population of wellcharacterized study participants.
Conclusions
We discovered associations between four gut microbiota genera (L. blautia, L. dorea, L. ruminococcus, and SHA-98) and BMI predictive plasma metabolites, including glutamate, BCAAs, and BCAA-related metabolites. This suggests that these metabolites could be mediators in the connection between gut microbiota and obesity and points to potential future opportunities for targeting the gut microbiota in the prevention of obesity.
